Detalhe da pesquisa
1.
Revisiting prostate cancer metabolism: From metabolites to disease and therapy.
Med Res Rev
; 41(3): 1499-1538, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274768
2.
Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function.
Molecules
; 26(10)2021 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34063349
3.
Sweet Cherry Extract Targets the Hallmarks of Cancer in Prostate Cells: Diminished Viability, Increased Apoptosis and Suppressed Glycolytic Metabolism.
Nutr Cancer
; 72(6): 917-931, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31507215
4.
Regucalcin counteracts tert-butyl hydroperoxide and cadmium-induced oxidative stress in rat testis.
J Appl Toxicol
; 37(2): 159-166, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27109168
5.
Effect of extracellular calcium on regucalcin expression and cell viability in neoplastic and non-neoplastic human prostate cells.
Biochim Biophys Acta
; 1853(10 Pt A): 2621-8, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26171977
6.
Suppressed glycolytic metabolism in the prostate of transgenic rats overexpressing calcium-binding protein regucalcin underpins reduced cell proliferation.
Transgenic Res
; 25(2): 139-48, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553531
7.
Histopathological and in vivo evidence of regucalcin as a protective molecule in mammary gland carcinogenesis.
Exp Cell Res
; 330(2): 325-335, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25128811
8.
Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.
Prostate
; 75(9): 923-35, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25786656
9.
Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways.
Prostate
; 74(12): 1189-98, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24975685
10.
The SCF/c-KIT system in the male: Survival strategies in fertility and cancer.
Mol Reprod Dev
; 81(12): 1064-79, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25359157
11.
Humulus lupulus aqueous extract and hydrolate as a potential ingredient for cosmetics: chemical characterization and in vitro antimicrobial, cytotoxicity, antioxidant and anti-inflammatory assessment.
Fitoterapia
; 175: 105861, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354824
12.
Androgens and low density lipoprotein-cholesterol interplay in modulating prostate cancer cell fate and metabolism.
Pathol Res Pract
; 240: 154181, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327818
13.
Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
Cell Oncol (Dordr)
; 44(2): 385-403, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464483
14.
Overexpression of regucalcin mitigates the ageing-related changes in oxidative stress and sperm quality.
Theriogenology
; 157: 472-482, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898822
15.
The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy.
Eur J Med Chem
; 171: 343-363, 2019 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30928707
16.
Tyrosine kinase inhibitor imatinib modulates the viability and apoptosis of castrate-resistant prostate cancer cells dependently on the glycolytic environment.
Life Sci
; 218: 274-283, 2019 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30605651
17.
Editorial: Fruits, vegetables and herbs: medicinal chemistry, metabolic and health effects.
Front Nutr
; 10: 1225577, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37502718
18.
Glucose and glutamine handling in the Sertoli cells of transgenic rats overexpressing regucalcin: plasticity towards lactate production.
Sci Rep
; 8(1): 10321, 2018 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29985416
19.
Estrogens down-regulate the stem cell factor (SCF)/c-KIT system in prostate cells: Evidence of antiproliferative and proapoptotic effects.
Biochem Pharmacol
; 99: 73-87, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26592659
20.
Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
J Cancer Res Clin Oncol
; 142(1): 5-16, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26048031